Institutional Ownership Bridge Bio Pharma, Inc. (BBIO)
This table provides information about the institutional ownership of Bridge Bio Pharma, Inc. (BBIO). We have compiled data on the 291 institutions that hold shares in the stock, with a total of 171 Million shares, which have been reported (via 13F filing form) to have a value of $3.98 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Wolff Wiese Magana LLC
|
Oct 16, 2024 Q3 2024 |
27
shares
|
$632
0.0% of portfolio
|
Q3 2024
New holding
|
|
Sjs Investment Consulting Inc.
Sylvania, OH |
Oct 16, 2024 Q3 2024 |
25
shares
|
$585
0.0% of portfolio
|
Q3 2024
Added 8.7%
|
|
Di Nuzzo Private Wealth, Inc.
Beaver, PA |
Oct 16, 2024 Q3 2024 |
23
shares
|
$538
0.0% of portfolio
|
Q3 2024
Added 4.55%
|
|
Colonial Trust Advisors
Spartanburg, SC |
Nov 12, 2024 Q3 2024 |
22
shares
|
$515
0.0% of portfolio
|
Q1 2024
New holding
|
|
Institutional & Family Asset Management, LLC
|
Jul 05, 2024 Q2 2024 |
13
shares
|
$304
0.0% of portfolio
|
Q4 2023
New holding
|
|
Pfg Private Wealth Management, LLC
|
Nov 05, 2024 Q3 2024 |
11
shares
|
$257
0.0% of portfolio
|
Q2 2024
New holding
|
|
Advisor Net Financial, Inc
|
Oct 15, 2024 Q3 2024 |
7
shares
|
$163
0.0% of portfolio
|
Q3 2024
New holding
|
|
Nomura Asset Management CO LTD
Tokyo, M0 |
Nov 15, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|